期刊文献+

苯那普利减轻幼龄肾病大鼠蛋白尿的研究 被引量:1

Study on the effect of benazepril on reducing proteinuria in a nephrotic young rat model
下载PDF
导出
摘要 目的 观察血管紧张素转换酶抑制剂苯那普利减轻幼龄肾病大鼠蛋白尿的作用。方法 对SD幼龄大鼠 (1个月龄 ,体重 10 0 g左右 )行单侧肾切除加阿霉素注射建立动物模型 ,术后即给予苯那普利 6mg·kg-1·d-1)治疗 12周 ,观察大鼠蛋白尿的变化。结果 于治疗的第 7、9、12周 ,苯那普利组 2 4h尿蛋白与同期模型组相比分别为 (7 34±4 36 )、(1 99± 1 2 4)、(5 18± 3 5 3)mg比 (14 44± 1 76 )、(17 48± 9 77)、(15 18± 4 71)mg (P均 <0 0 1)。 结论 在单侧肾切除后 1周注射阿霉素的幼龄SD肾病大鼠动物模型中 。 Objective To observe the effect of benazepril, an angiotensin converting enzyme inhibitor (ACEI) , on reducing proteinuria in a nephrotic young rat model of with massive proteinuria. Methods Animal model was made by uninephrectomy and following adriamycin (5 mg·kg -1 ) injected after one week through the tail vein in SD young rats (one month old, weighing 100 g±12 g). After uninephrectomy, the young rats were treated with benazepril 6 mg·kg -1 ·d -1 for 12 weeks. The proteinuria, the serum total protein and albumin and the serum cholesterol were measured at regular intervals. Results At 7, 9 and 12 weeks, proteinuria of benazepril group compared to one of model group is 7 34±4 36 vs 14 44±1 76, 1 99±1 24 vs 17 48±9 77 and 5 18±3 53 vs 15 18±4 71 mg·(24 h) -1 , P <0 01, respectively. Conclusion These results indicate that benazepril showed a reducing proteinuria property in a nephrotic animal model that was made by injecting adriamycin after one week of uninephrectomy in SD young rats.
出处 《安徽医科大学学报》 CAS 2000年第6期449-451,共3页 Acta Universitatis Medicinalis Anhui
基金 CMB基金资助项目!(935 93)
关键词 蛋白尿 肾疾病 药物治疗 苯那普利 大鼠 antiotensin converting enzyme inhibitors/ther used proteinuria/drug therapy kidney diseases/drug therapy
  • 相关文献

参考文献9

  • 1[1]Ziai F, Ots M, Provoost AP et al. The angiotensin receptor agtagonist,irbesartan,reduces renal injury in experimental chronic renal failure. Kidney Int, 1996;50(suppl 57):s132~s136
  • 2[2]Tanaka R, Kon V, Yoshioka T et al. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by discinct mechanisms. Kidney Int, 1994;45(2):537~543
  • 3[3]Ichikawa I. Will angiotensin II receptor antagonists be renoprotective in humans ? Kidney Int. 1996;50(2):684~692
  • 4[4]Matsusake T, Hymes J, Ichikawa I. Angiotensin in progressive renal diseases. Therapy and practice. J Am Soc Nephrol, 1996;7(10):2 025~2 034
  • 5[5]Zoja C, Donadelli R, Corna D et al. The renoprotective properties of angiotensin converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis, 1997;29(2):254~264
  • 6[6]Huissoon AP, Meehan S, Keogh JA. Reduction of proteinuria with captopril therapy in patients with focal segmental glomerulosclerosis and IgA nephropathy. Ir J Med Sci,1991;160(10):319~321
  • 7[7]Novick AC, Schreiber-MJ Jr. Effect of angiotensin converting enzyme inhibitor on nephropathy in patients with a remnant kidney. Urology, 1995;46(6):785~789
  • 8[8]Mizuno S, Mizuno-Horikawa Y, Okamoto M et al. Angiotensin converting enzyme inhibitor suppresses tubular expression of platelet-derived growth factor and attenuates progression of tubulo-interstitial fibrosis in a nephrotic mouse model. Nephron,1998;79(4):503~504
  • 9[9]Irwin KC, Brouhard BH, Satoh S et al. Effects of enalapril on adriamycin-induced nephrosis. Pediatr Nephrol,1992;6(5):448~450

同被引文献8

  • 1Nagata M, Schaer K, Kriz W. Glomerular damage after uninephrectomy in young rats. Ⅰ Hypertrophy and distortion of capillary architecture. Kidney Int, 1992, 42(1) : 136-47.
  • 2Tanaka R, Kon V, Yoshioka T et al. Angiotensin converting enzyme inhibitor modulates glomerular function and structure by discinct mechanisms. Kidney Int, 1994, 45(2): 537-43.
  • 3Ichikawa I. Will angiotensin Ⅱ receptor antagonists be renoprotective in humans? Kidney Int, 1996, 50(2): 684-92.
  • 4Matsusake T, Hymes J, Ichikawa I. Angiotensin in progressive renal diseases. Therapy and practice. J Am Soc Nephrol, 1996,7 (10): 2025-34.
  • 5Shibouta Y, Chatani F, Ishimura Y et al. TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.Kidney Int, 1996, 49(Suppl 55): 115-8.
  • 6Noda M, Fukuda R, Matsuo T et al. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.Kidney Int, 1997, 52(Suppl 63): 136-9.
  • 7周富华,王笑云.氯沙坦及苯那普利对慢性肾衰大鼠肾功能和细胞凋亡的影响[J].肾脏病与透析肾移植杂志,1999,8(4):330-332. 被引量:6
  • 8卢筱华,冯烈,许敏华.氯沙坦对糖尿病大鼠肾脏保护作用的探讨[J].中华肾脏病杂志,2000,16(3):182-185. 被引量:40

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部